Financial statements Amberpharm
Balance sheet of Amberpharm
Company age:
Age:
6 y. 10 m. 27 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of AMBERPHARM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 5 000,00 | 1 776 137,75 | 1 238 737,57 | 1 000 043,51 | 691 342,65 |
| A. Fixed assets | 0,00 | 112 442,74 | 205 794,24 | 225 330,92 | 224 823,23 |
| B. Current assets | 0,00 | 1 658 695,01 | 1 027 943,33 | 774 712,59 | 466 519,42 |
| C. Share capital contributions (basic funds) | 5 000,00 | 5 000,00 | 5 000,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | - | - | - |
| Total liabilities | 5 000,00 | 1 776 137,75 | 1 238 737,57 | 1 000 043,51 | 691 342,65 |
| A. Equity | -18 506,58 | -417 424,88 | 713 344,23 | 725 405,73 | 680 080,57 |
| B. Liabilities and provisions for liabilities | 23 506,58 | 2 193 562,63 | 525 393,34 | 274 637,78 | 11 262,08 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 23 506,58 | 2 146 988,57 | 525 393,34 | 274 637,78 | 11 262,08 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.